IAN F SMITH
CIK 1197032 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.50M
Companies
9
Total Filings
148
Lifetime Open-Market Net
-$163.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLDB | Director | 134,705 | $7.14 | $961.8K | $0 | 29 | 2026-06-11 |
| ODTX | Director | — | — | — | $0 | 1 | 2026-05-11 |
| STOK | Chief Executive Officer | — | $29.82 | — | $0 | 5 | 2026-02-19 |
| FHTX | Director | — | $4.18 | — | $0 | 7 | 2025-06-17 |
| VRTX | EVP, COO | 75,380 | $444.93 | $33.54M | -$162.37M | 74 | 2018-07-03 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | 0 | $0.66 | $0 | -$1.58M | 16 | 2018-06-29 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | 45,845 | $0.04 | $2.0K | $0 | 12 | 2018-06-14 |
| IVERIC bio, Inc. (OPHT) Delisted | Director | — | — | — | $0 | 1 | 2016-08-04 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 2 | 2008-05-21 |
Recent Filings · Page 7 of 15
148 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-21 | VRTX | Mixed | −10,350 | -$11.15M | EDGAR |
| 2017-06-05 | VRTX | Mixed | — | -$7.89M | EDGAR |
| 2017-06-02 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-26 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | +22,988 | $40.0K | EDGAR |
| 2017-05-17 | VRTX | Sell (S) | −294 | -$33.8K | EDGAR |
| 2017-03-02 | VRTX | Sell (S) | −3,842 | -$345.8K | EDGAR |
| 2017-02-15 | VRTX | Sell (S) | −3,842 | -$336.8K | EDGAR |
| 2017-02-07 | VRTX | Grant (A) | +20,923 | $58 | EDGAR |
| 2017-01-09 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-04 | IVERIC bio, Inc. (OPHT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.